The diagnostic value of marginal zone enhancement features of contrast-enhanced ultrasound in the benign and malignant breast masses identification of BI-RADS 4
CHEN Fei JIA Chunmei LYU Qi WANG Jingjie HU Tian
Department of Ultrasound, the First Hospital of Shanxi Medical University, Shanxi Province, Taiyuan 030001, China
Abstract：Objective To explore the diagnostic value of two-dimensional ultrasound (2D-US) and contrast-enhanced ultrasound features in marginal zone for benign and malignant breast masses in BI-RADS 4. Methods From January 2016 to July 2018, 76 patients were collected from the Department of Ultrasound, the First Affiliated Hospital of Shanxi Medical University. A total of 77 breast masses were confirmed by biopsy or surgical pathology. Benign and malignant tumors were divided into two groups. 2D-US and contrast-enhanced ultrasound characteristics of marginal zone in benign and malignant tumors were compared. And the marginal zone and the inside of the masses time-intensity curve (TIC) parameters of the benign and malignant groups were analyzed. Base strength (BI), peak intensity (PI), area under the curve (AUC), peak time (TTP), and gradient (Grad) were observed. They were analyzed for 3 times and the average value was taken. Results Compared with benign group, 2D-US of malignant group showed more irregular edge, spiculate margin, acoustic halo and lobulated edge, the differences were statistically significant (P < 0.05). Contrast-enhanced ultrasound showed radial enhancement, perforator enhancement and circular enhancement, perforation enhancement, unclear boundary, enlarged range after angiography were more common in malignant group, the differences were statistically significant (P < 0.05). In malignant group, BI, PI, AUC and Grad were bigger in marginal zone than the inside of the masses, and TTP was faster than the inside of the mass, the differences were statistically significant (P < 0.05). In benign group, the marginal zone of lesion was not significantly different from the internal mass in the above parameters (P > 0.05). Conclusion There are significant differences between the benign and malignant masses in the 2D-US and contrast-enhanced ultrasound of the marginal zone. The ultrasound signs of the marginal zone of the malignant masses contribute more to the diagnosis of breast cancer than the internal, therefore, focusing on the marginal zone ultrasound characteristics can improve the ability of differential diagnosis between benign and malignant breast mass.
陈菲 贾春梅 吕琪 王婧婕 胡田. 超声造影边缘增强特征对BI-RADS 4类乳腺肿块良、恶性鉴别的诊断价值[J]. 中国医药导报, 2019, 16(28): 154-157.
CHEN Fei JIA Chunmei LYU Qi WANG Jingjie HU Tian. The diagnostic value of marginal zone enhancement features of contrast-enhanced ultrasound in the benign and malignant breast masses identification of BI-RADS 4. 中国医药导报, 2019, 16(28): 154-157.
[1] D’Orsi CJ，Bassett LW，Berg WA，et al. Breast Imaging Reporting and Data System：ACR BI-RADS-Mammography [M]. 4th ed. Reston，VA：American College of Radiology，2003.
[2] 李志宇，何之彦.乳腺癌间质反应的影像学表现研究进展[J].医学影像学杂志，2012，22（4）：669-671.
[3] 吴娟，孙圣荣，袁静萍.肿瘤微环境与乳腺癌[J].中国组织化学与细胞化学杂志，2018，27（1）：82-86.
[4] 赵妮，姚秀芬，赵素萍.乳腺癌彩色多普勒超声与细胞蛋白表达的相关性研究[J].中国临床医学影像杂志，2016， 27（7）：462-466.
[5] 陈红梅.乳腺癌间质反应的X线表现与其侵袭程度关系的研究[D].郑州：郑州大学，2013.
[6] 徐海燕，赵红，邹立巍，等.利用3.0T MR血管成像探讨乳腺癌周围血供特点及相关因素[J].中华全科医学，2016， 14（1）：108-110.
[7] 杨晓婧，王法，娜迪热·铁列吾汗.超声造影在乳腺癌新辅助化疗疗效评价中的价值[J].中华实用诊断与治疗杂志，2016，30（4）：396-398.
[8] Mcphail LD，Robinson SP. Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors：relationship to histologic assessment of hypoxia and fibrosis [J]. Radiology，2010，254（1）：110-118.
[9] Zeng RX，Huang W，Zou Q，et al. MRI in the diagnosis of breast cancer and the correlation between expression of specific receptors and MVD [J]. Journal of Southeast University：Medical Science Edition，2016，35（5）：731-736.
[10] 左玮玮，贾亚男，齐赛.乳腺癌钼靶X线肿块边缘征象与Her-2表达的相关性分析[J].河北医科大学学报，2017， 38（4）：485-488.
[11] 卓家伟，何以敉，张美恋，等.乳腺癌常规超声及剪切波弹性成像表现与淋巴结转移关系的研究[J].中华超声影像学杂志，2018，27（8）：709-713.
[12] 黄小莉，黄向红，王小燕，等.三阴性乳腺癌与非三阴性乳腺癌的超声造影特征探讨[J].中国超声医学杂志，2016，32（9）：844-847.
[13] Sarica O，Kaymaz G，Ucar N. Effectiveness of Additional Diagnostic Parameters in Magnetic Resonance Mammography：A Comparative Study with the BI-RADS Classification and Scoring System [J]. J Comput Assist Tomogr，2014，38（6）：985-991.
[14] 曾茹雪，黄文，邹庆，等.乳腺癌磁共振诊断表现与特异受体表达和微血管密度特征的相关性研究[J].东南大学学报：医学版，2016，35（5）：731-736.
[15] Goddard LM，Iruela-Arispe ML. Cellular and molecular regulation of vascular permeability [J]. Thromb Haemost，2013，109（3）：407-415.
[16] Wong PP，Demircioglu F，Ghazaly E，et al. Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread [J]. Cancer Cell，2015， 27（1）：123-137.
[17] 李颖嘉，文戈，何洁.超声造影定量分析对乳腺良恶性肿瘤血流灌注异质性的评价[J].中华超声影像学杂志，2009，18（6）：517-520.
[18] 王小燕，贺琰，凌冰，等.乳腺肿块的超声造影特征与病理对照分析[J].中华肿瘤防治杂志，2016，23（10）：667-671，676.
[19] 柯霓，陈文卫.乳腺良恶性结节的超声造影模式与病理学对比分析[J].武汉大学学报：医学版，2018，39（4）：536-540.
[20] 郭勇军.多普勒超声在乳腺癌诊断中的应用[J].中外医学研究，2018，16（2）：60-61.
[21] 李颖嘉，文戈，杨莉.超声造影及其定量分析对乳腺癌恶性转化过程中血管生成作用的评价[J].中华医学杂志，2009，89（9）：587-591.
[22] 李超，李明，刘现栋，等.乳腺超声与钼靶X线检查对乳腺癌影像学表现的对比分析[J].医学综述，2017，23（23）：4752-4755，4761
[23] 罗晔.超声检查对乳腺肿瘤的诊断价值[J].中外医学研究，2018，16（23）：60-61.
[24] 刘真，赵继革，刘全新.高频彩色超声对乳腺导管内乳头状瘤的诊断价值分析[J].中外医学研究，2017，15（30）：67-69.
2019, Vol. 16 
京公网安备 11010502046598号